Glucocorticoid receptor modulators as antiinflammatory agents

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S375000, C514S378000, C514S381000, C514S621000, C544S105000, C548S230000, C548S245000, C548S253000, C564S169000

Reexamination Certificate

active

07348322

ABSTRACT:
The present invention relates to compounds of formula I:wherein A, X, R1, R2and R3are as defined herein and pharmaceutically acceptable salts thereof. The invention also relates to methods of using the compounds of formula I and pharmaceutical compositions comprising the compounds of formula I.

REFERENCES:
patent: 6245804 (2001-06-01), Lehmann et al.
patent: 6323199 (2001-11-01), Lehmann et al.
patent: 6344454 (2002-02-01), Lehmann et al.
patent: 6380207 (2002-04-01), Coghlan et al.
patent: 6548534 (2003-04-01), Lehmann et al.
patent: 6903215 (2005-06-01), Betageri et al.
patent: 2002/0077356 (2002-06-01), Jaroch et al.
patent: 2004/0254249 (2004-12-01), Jaroch et al.
patent: WO 98/54159 (1998-12-01), None
patent: WO 02/10143 (2002-02-01), None
Betageri, R., et. al., “Trifluoromethyl Group as a Pharmacophore: Effect of Replacing a CF3Group on Binding and Agonist Activity of a Glucocorticoid Receptor Ligand,”Bioorg. Med. Chem. Lett. (2005) 15, pp. 4761-4769.
Barnes, P.J., “Anti-inflammatory actions of glucocorticoids: molecular mechanisms”,Clinical Science(1998) 94, 557-572.
Schacke, H. et al., “Mechanisms involved in the side effects of glucocorticoids”,Pharmacology&Therapeutics(2002) 96, 23-42.
Heck, S. et al., “A distinct modulating domain in glucorticoid receptor monomers in the repression of activity of the transcription factor AP-1”,EMBO J., 1994 vol. 13 (17) pp. 4087-4095.
Prakash, G.K.S. et al., “Perfluoroalkylation with Organosilicon Reagents”,Chem. Rev. 1997, 97, pp. 757-786.
Ramalah, P. et al., “Direct Trifluoromethylation of a-Keto Esters to b,b,b-Trifluorolactic Acid Derivates Using Trifluoromethyltrimethylsilane”,Synlett, 1991 (09), pp. 643-644.
Reichardt, H.M. et al., “DNA Binding of the Glucocorticoid Receptor is Not Essential for Survival”,Cell, 1998 vol. 93, pp. 531-541.
Tronche, F. et al., “Genetic dissection of Glucocorticoid receptor function in mice”,Curr Opin Genet Dev., 1998, 8 (5) pp. 532-538.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Glucocorticoid receptor modulators as antiinflammatory agents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Glucocorticoid receptor modulators as antiinflammatory agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glucocorticoid receptor modulators as antiinflammatory agents will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3968585

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.